Brain-wave studies suggest potential markers of Huntington's disease
A systematic review found recurring electrical-activity patterns, alongside inconsistent results that leave their clinical usefulness unresolved.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review found recurring differences in brain-wave patterns in Huntington's disease, and some measures were associated with greater cognitive or movement impairment. These findings support further investigation of EEG as a possible marker of disease-related changes. They do not establish a validated diagnostic test or show that EEG can guide treatment decisions.
The abstract supplies no pooled effect sizes or diagnostic accuracy estimates. Its call for larger studies and standardized methods means an abstract-based summary cannot establish how reliably these patterns identify or track disease.
Patterns differed by recording condition
At rest, studies commonly reported lower alpha and delta wave power, while theta and beta results varied. During sleep, lower theta power was reported. These labels describe different components of the recorded brain-wave signal.
Clinical associations remain preliminary
Lower alpha and theta power were associated with worse thinking and movement function. Medication-related findings were mostly nonsignificant, with an exception involving spindle density in an unmedicated group; these results do not establish medication effects.
The original publication
Electroencephalography biomarkers in Huntington's disease: A systematic review of resting-state and sleep EEG alterations.
Jalali S, Asadollahi M, Gouravani M et al.
Clin Neurophysiol · 2026
- PubMed ID
- 41747657
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.